Literature DB >> 33731812

Cystic fibrosis and noninvasive liver fibrosis assessment methods in children.

Raphael Enaud1,2,3, Eric Frison4,5, Sophie Missonnier6, Aude Fischer1, Victor de Ledinghen7, Paul Perez4,5, Stéphanie Bui2, Michael Fayon2,3,5, Jean-François Chateil6,8, Thierry Lamireau9,10.   

Abstract

BACKGROUND: Noninvasive assessments of liver fibrosis are currently used to evaluate cystic fibrosis (CF)-related liver disease. However, there is scarce data regarding their repeatability and reproducibility, especially in children with CF. The present study aimed to evaluate the repeatability and reproducibility of transient elastography (TE) (FibroScan®) and point shear-wave elastography using virtual touch quantification (pSWE VTQ) in children with CF.
METHODS: TE and pSWE VTQ were performed in 56 children with CF by two different operators. Analysis of repeatability and reproducibility was available in 33 patients for TE and 46 patients for pSWE VTQ. Intra- and interobserver agreement were assessed using the intraclass correlation coefficient (ICC) and their 95% confidence interval (CI), and Bland and Altman graphs.
RESULTS: For TE, ICC was 0.91 (0.83-0.95) for intraobserver agreement and 0.92 (95% CI: 0.86-0.96) for interobserver agreement. For pSWE VTQ, ICC was 0.83 (0.72-0.90) for intraobserver agreement and 0.67 (0.48-0.80) for interobserver agreement.
CONCLUSIONS: Both technics can be proposed in the follow-up of patients, according to their availability in CF centers. IMPACT: This study shows that TE and pSWE VTQ are reliable methods to evaluate liver fibrosis in children with CF. This study shows for the first time that TE and pSWE VTQ are both repeatable and reproducible in children with CF. These data indicate that both TE and pSWE VTQ can be proposed for the follow-up of patients with CF, according to their availability in each CF center.
© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33731812     DOI: 10.1038/s41390-021-01427-4

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.953


  40 in total

1.  Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives.

Authors:  Dominique Debray; Michael R Narkewicz; Frank A J A Bodewes; Carla Colombo; Chantal Housset; Hugo R de Jonge; Johan W Jonker; Deirdre A Kelly; Simon C Ling; Thierry Poynard; Philippe Sogni; Michael Trauner; Peter Witters; Ulrich Baumann; Michael Wilschanski; Henkjan J Verkade
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-10       Impact factor: 2.839

2.  Ursodeoxycholic acid treatment is associated with improvement of liver stiffness in cystic fibrosis patients.

Authors:  Cathelijne van der Feen; Hubert P J van der Doef; Cornelis K van der Ent; Roderick H J Houwen
Journal:  J Cyst Fibros       Date:  2016-11       Impact factor: 5.482

Review 3.  Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease.

Authors:  Dominique Debray; Deirdre Kelly; Roderick Houwen; Birgitta Strandvik; Carla Colombo
Journal:  J Cyst Fibros       Date:  2011-06       Impact factor: 5.482

4.  Transient elastography and portal hypertension in pediatric patients with cystic fibrosis Transient elastography and cystic fibrosis.

Authors:  A C Malbrunot-Wagner; L Bridoux; J B Nousbaum; C Riou; A Dirou; J L Ginies; C Maurage; B Cagnard; C Pelatan; A Dabadie
Journal:  J Cyst Fibros       Date:  2011-05-07       Impact factor: 5.482

5.  Can Point Shear Wave Elastography Be Used as an Early Indicator of Involvement?: Evaluation of the Pancreas and Liver in Children With Cystic Fibrosis.

Authors:  Dilek Sağlam; Fatma Demirbaş; Meltem Ceyhan Bilgici; Serap Yücel; Gönül Çaltepe; Esra Eren
Journal:  J Ultrasound Med       Date:  2020-04-20       Impact factor: 2.153

6.  Epidemiology of liver disease in cystic fibrosis: a longitudinal study.

Authors:  Thierry Lamireau; Sylvie Monnereau; Steven Martin; Jacques-Edouard Marcotte; Maria Winnock; Fernando Alvarez
Journal:  J Hepatol       Date:  2004-12       Impact factor: 25.083

7.  TIMP-1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease.

Authors:  Timo Rath; Katrin Menendez Menendez; Marion Kügler; Lisa Hage; Christian Wenzel; Richard Schulz; Jürgen Graf; Lutz Nährlich; Elke Roeb; Martin Roderfeld
Journal:  Dig Liver Dis       Date:  2012-05-29       Impact factor: 4.088

8.  Transient elastography in patients with cystic fibrosis.

Authors:  Renaud Menten; Anissa Leonard; Philippe Clapuyt; Pierre Vincke; Alexandra-Cristina Nicolae; Patrick Lebecque
Journal:  Pediatr Radiol       Date:  2010-02-05

9.  Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease.

Authors:  Peter Witters; Kris De Boeck; Lieven Dupont; Marijke Proesmans; François Vermeulen; Roger Servaes; Chris Verslype; Wim Laleman; Frederik Nevens; Ilse Hoffman; David Cassiman
Journal:  J Cyst Fibros       Date:  2009-09-04       Impact factor: 5.482

10.  Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.

Authors:  Pierre-Yves Boëlle; Dominique Debray; Loic Guillot; Annick Clement; Harriet Corvol
Journal:  Hepatology       Date:  2018-12-28       Impact factor: 17.425

View more
  1 in total

1.  Non-invasive tools for detection of liver disease in children and adolescents with cystic fibrosis.

Authors:  Antonella Tosco; Angela Sepe; Alice Castaldo; Andrea Catzola; Chiara Cimbalo; Valentina Angelini; Gianfranco Vallone; Roberto Buzzetti; Valeria Raia; Maria Grazia Caprio
Journal:  Transl Pediatr       Date:  2021-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.